10
Participants
Start Date
December 31, 2012
Primary Completion Date
December 31, 2015
Study Completion Date
January 31, 2016
Aflibercept
Aflibercept: 4mg/kg IV q2weeks until progression for a maximum of 2 years
Rhode Island Hospital (East Greenwich and Newport), Providence
The Miriam Hospital, Providence
Lead Sponsor
Collaborators (1)
Rhode Island Hospital
OTHER
The Miriam Hospital
OTHER
Lifespan
OTHER
University of California, San Diego
OTHER
Montefiore Medical Center
OTHER
University of Florida
OTHER
Sanofi
INDUSTRY
Brown University
OTHER